(Reuters) - Israel's Teva Pharmaceutical Industries Ltd said it would buy U.S. drug developer Auspex Pharmaceuticals Inc for $3.5 billion to boost its portfolio of treatments for the central nervous system.
via Reuters: Health News Read More Here..
No comments:
Post a Comment